Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of metabolic disorders. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://joanqxnf593208.bloginwi.com/72588871/semaglutide-a-potential-solution-for-obesity